Loading...

Home
ETF
RNA

RNA

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

RNA News

Avidity Biosciences Announces Share Distribution for Spin-Off

Feb 03 2026Newsfilter

Avidity Biosciences Announces Spin-Off Plan

Feb 03 2026PRnewswire

Halper Sadeh LLC Investigates Multiple Companies for Securities Violations

Jan 31 2026Globenewswire

Earnings Momentum Review: BAX and Others Rated D

Jan 16 2026seekingalpha

Biotech Stocks Surge at Year-End 2025, ETFs Gain 35.84%

Dec 31 2025Benzinga

Two Health Care Stocks That Could Cause You Concern This December

Dec 16 2025Benzinga

ETF Outflow Warning: XBI, EXAS, RVMD, RNA

Dec 11 2025NASDAQ.COM

Oppenheimer Upgrades Dyne Ahead of Avidity's Upcoming Trial Results

Dec 10 2025SeekingAlpha

Significant ETF Inflows: XBI, EXAS, RVMD, RNA

Dec 03 2025NASDAQ.COM

Avidity Biosciences Acquired by Novartis for $72 per Share

Dec 02 2025PRnewswire

Sarepta's Shares Climb Following Encouraging News on DM1 Treatment

Nov 25 2025NASDAQ.COM

Halper Sadeh LLC Urges WTRG, RNA, TCBX Shareholders to Reach Out for Rights Consultation

Nov 21 2025Globenewswire

15 Stocks That Continue to Show Momentum and Outperform the Market

Nov 20 2025MarketWatch

Novartis Anticipates Accelerated Growth by 2030 Following Increased Drug Projections

Nov 20 2025Benzinga

Novartis Anticipates Consistent Sales Increase Until 2030

Avidity Biosciences Launches U.S. Managed Access Program for Investigational Therapy del-zota in DMD44

Nov 19 2025Newsfilter